Ruth A. Salmon

572 total citations
15 papers, 473 citations indexed

About

Ruth A. Salmon is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Ruth A. Salmon has authored 15 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Ruth A. Salmon's work include CAR-T cell therapy research (8 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Ruth A. Salmon is often cited by papers focused on CAR-T cell therapy research (8 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Immune Cell Function and Interaction (3 papers). Ruth A. Salmon collaborates with scholars based in Canada, United States and Switzerland. Ruth A. Salmon's co-authors include John W. Schrader, Ian N. Foltz, Odd‐Arne Olsen, John S. Babcook, Kevin B. Leslie, Peter R. Young, James S. Wieler, Robert E. Gerl, Timothy G. Johnstone and Jon C. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Ruth A. Salmon

15 papers receiving 461 citations

Peers

Ruth A. Salmon
Farha H. Vasanwala United States
Aaron Y. Chang United States
J Xiang Canada
Eric Routhier United States
Liangpeng Yang United States
Gregory J. Duigou United States
Laurie Graham United States
Svetlana M. Mazel United States
Jan Winter Germany
Sharon Lam United States
Farha H. Vasanwala United States
Ruth A. Salmon
Citations per year, relative to Ruth A. Salmon Ruth A. Salmon (= 1×) peers Farha H. Vasanwala

Countries citing papers authored by Ruth A. Salmon

Since Specialization
Citations

This map shows the geographic impact of Ruth A. Salmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth A. Salmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth A. Salmon more than expected).

Fields of papers citing papers by Ruth A. Salmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth A. Salmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth A. Salmon. The network helps show where Ruth A. Salmon may publish in the future.

Co-authorship network of co-authors of Ruth A. Salmon

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth A. Salmon. A scholar is included among the top collaborators of Ruth A. Salmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth A. Salmon. Ruth A. Salmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Qin, Jim, Timothy G. Johnstone, Ronald J. Hause, et al.. (2020). Antitumor Potency of an Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, Lisocabtagene Maraleucel in Combination With Ibrutinib or Acalabrutinib. Journal of Immunotherapy. 43(4). 107–120. 60 indexed citations
3.
Works, Melissa, Neha Soni, Jon C. Jones, et al.. (2019). Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T cell Function against Multiple Myeloma Is Enhanced in the Presence of Lenalidomide. Molecular Cancer Therapeutics. 18(12). 2246–2257. 72 indexed citations
4.
Jessup, Heidi K., Evan P. Thomas, Jim Qin, et al.. (2019). Abstract 2320: Avadomide (CC-122) increases effector function and reverses exhaustion in chronically stimulated lisocabtagene maraleucel anti-CD19 CAR T drug product. Cancer Research. 79(13_Supplement). 2320–2320. 1 indexed citations
5.
Works, Melissa, Neha Soni, Jon C. Jones, et al.. (2017). Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma. Blood. 130. 1794–1794. 2 indexed citations
6.
7.
Welstead, G. Grant, Justin Fang, Frank A. Buquicchio, et al.. (2016). 572. Successful Generation of CAR+PD-1-Primary T Cells Using Cas9-Mediated Genome Editing. Molecular Therapy. 24. S229–S229. 2 indexed citations
8.
Scalley‐Kim, Michelle, Bruce W. Hess, Ryan L. Kelly, et al.. (2012). A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation. PLoS ONE. 7(8). e43332–e43332. 6 indexed citations
9.
Hunt, David W. C., et al.. (2006). Ultraviolet B Light Stimulates lnterleukin‐20 Expression by Human Epithelial Keratinocytes. Photochemistry and Photobiology. 82(5). 1292–1300. 22 indexed citations
10.
Salmon, Ruth A., Xuecui Guo, Hung‐Sia Teh, & John W. Schrader. (2001). The p38 mitogen-activated protein kinases can have opposing roles in the antigen-dependent or endotoxin-stimulated production of IL-12 and IFN-γ. European Journal of Immunology. 31(11). 3218–3227. 23 indexed citations
11.
12.
Salmon, Ruth A., Ian N. Foltz, Peter R. Young, & John W. Schrader. (1997). The p38 mitogen-activated protein kinase is activated by ligation of the T or B lymphocyte antigen receptors, Fas or CD40, but suppression of kinase activity does not inhibit apoptosis induced by antigen receptors. The Journal of Immunology. 159(11). 5309–5317. 81 indexed citations
13.
Babcook, John S., Kevin B. Leslie, Odd‐Arne Olsen, Ruth A. Salmon, & John W. Schrader. (1996). A novel strategy for generating monoclonal antibodies from single, isolated lymphocytes producing antibodies of defined specificities.. Proceedings of the National Academy of Sciences. 93(15). 7843–7848. 107 indexed citations
14.
Salmon, Ruth A.. (1982). The role of coercion in rehabilitation of drug abusers. Journal of Offender Rehabilitation. 6(4). 59–70. 3 indexed citations
15.
Dodd, Roger Y., et al.. (1975). The Solid Phase Radioimmunoassay Technique for Hepatitis B (Surface) Antigen: Effects of Progressive Modification. Transfusion. 15(6). 608–611. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farha H. Vasanwala Breakdown of academic impact, for papers by Aaron Y. Chang Breakdown of academic impact, for papers by J Xiang Breakdown of academic impact, for papers by Eric Routhier Breakdown of academic impact, for papers by Liangpeng Yang Breakdown of academic impact, for papers by Gregory J. Duigou Breakdown of academic impact, for papers by Laurie Graham Breakdown of academic impact, for papers by Svetlana M. Mazel Breakdown of academic impact, for papers by Jan Winter Breakdown of academic impact, for papers by Sharon Lam
Rankless by CCL
2026